DK1305437T3 - Ekspression af biologisk aktive polypeptider i andemad - Google Patents

Ekspression af biologisk aktive polypeptider i andemad

Info

Publication number
DK1305437T3
DK1305437T3 DK01967946.3T DK01967946T DK1305437T3 DK 1305437 T3 DK1305437 T3 DK 1305437T3 DK 01967946 T DK01967946 T DK 01967946T DK 1305437 T3 DK1305437 T3 DK 1305437T3
Authority
DK
Denmark
Prior art keywords
duckweed
expression
biologically active
active polypeptides
polypeptide
Prior art date
Application number
DK01967946.3T
Other languages
English (en)
Inventor
John Gasdaska
Anne-Marie Stomp
Lynn Dickey
Original Assignee
Biolex Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolex Therapeutics Inc filed Critical Biolex Therapeutics Inc
Application granted granted Critical
Publication of DK1305437T3 publication Critical patent/DK1305437T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK01967946.3T 2000-07-31 2001-07-26 Ekspression af biologisk aktive polypeptider i andemad DK1305437T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22170500P 2000-07-31 2000-07-31
US29333001P 2001-05-23 2001-05-23
PCT/US2001/023400 WO2002010414A2 (en) 2000-07-31 2001-07-26 Expression of biologically active polypeptides in duckweed

Publications (1)

Publication Number Publication Date
DK1305437T3 true DK1305437T3 (da) 2010-12-13

Family

ID=26916048

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01967946.3T DK1305437T3 (da) 2000-07-31 2001-07-26 Ekspression af biologisk aktive polypeptider i andemad

Country Status (13)

Country Link
US (4) US6815184B2 (da)
EP (1) EP1305437B1 (da)
JP (1) JP4795619B2 (da)
CN (2) CN101676400A (da)
AT (1) ATE479761T1 (da)
AU (2) AU2001288226B2 (da)
CA (1) CA2417415C (da)
CY (1) CY1110959T1 (da)
DE (1) DE60142971D1 (da)
DK (1) DK1305437T3 (da)
NZ (1) NZ523912A (da)
PT (1) PT1305437E (da)
WO (1) WO2002010414A2 (da)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032211A1 (en) * 1996-09-26 2005-02-10 Metabogal Ltd. Cell/tissue culturing device, system and method
IL155588A0 (en) * 2003-04-27 2003-11-23 Metabogal Ltd Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
US7161064B2 (en) * 1997-08-12 2007-01-09 North Carolina State University Method for producing stably transformed duckweed using microprojectile bombardment
WO1999019497A1 (en) 1997-10-10 1999-04-22 Yeda Research And Development Co. Ltd. Transgenic lemnaceae
US8022270B2 (en) * 2000-07-31 2011-09-20 Biolex Therapeutics, Inc. Expression of biologically active polypeptides in duckweed
DK1305437T3 (da) * 2000-07-31 2010-12-13 Biolex Therapeutics Inc Ekspression af biologisk aktive polypeptider i andemad
US7959910B2 (en) 2000-07-31 2011-06-14 Biolex Therapeutics, Inc. C-terminally truncated interferon alpha variants
US7632983B2 (en) 2000-07-31 2009-12-15 Biolex Therapeutics, Inc. Expression of monoclonal antibodies in duckweed
US20030100945A1 (en) 2001-11-23 2003-05-29 Mindguard Ltd. Implantable intraluminal device and method of using same in treating aneurysms
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
US20100196345A1 (en) * 2003-04-27 2010-08-05 Protalix Production of high mannose proteins in plant culture
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
US7176024B2 (en) * 2003-05-30 2007-02-13 Biolex, Inc. Bioreactor for growing biological materials supported on a liquid surface
ES2672640T3 (es) * 2003-11-05 2018-06-15 Roche Glycart Ag Moléculas de unión a antígeno con afinidad de unión a receptores Fc y función efectora incrementadas
RU2394103C2 (ru) * 2004-02-11 2010-07-10 Биолекс Терапьютикс, Инк. Экспрессия плазминогена и микроплазминогена в ряске
ATE445009T1 (de) * 2004-06-14 2009-10-15 Novozymes As Signalpeptid zur herstellung eines polypeptids
US7527947B2 (en) 2004-06-14 2009-05-05 Novozymes A/S Signal peptide for producing a polypeptide
US20060024272A1 (en) * 2004-07-29 2006-02-02 Large Scale Biology Corporation C-terminally truncated interferon
BRPI0607315B1 (pt) 2005-02-07 2022-05-17 Roche Glycart Ag Molécula de ligação ao antígeno anti-egfr humanizada e seus usos, composição farmacêutica, e método para detectar a presença de egfr em uma amostra
KR20070114324A (ko) * 2005-03-25 2007-11-30 글리카트 바이오테크놀로지 아게 Ｍｃｓｐ 에 향하며 증가된 ｆｃ 수용체 결합 친화도 및효과기 작용을 갖는 항원 결합 분자
WO2007039818A2 (en) * 2005-05-09 2007-04-12 Glycart Biotechnology Ag Antigen binding molecules having modified fc regions and altered binding to fc receptors
TWI478940B (zh) 2005-08-26 2015-04-01 Roche Glycart Ag 具有經改變細胞傳訊活性之改質抗原結合分子
US7622573B2 (en) * 2006-01-17 2009-11-24 Biolex, Inc. Expression control elements from the lemnaceae family
WO2007084672A2 (en) * 2006-01-17 2007-07-26 Medarex, Inc. Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
AR062223A1 (es) * 2006-08-09 2008-10-22 Glycart Biotechnology Ag Moleculas de adhesion al antigeno que se adhieren a egfr, vectores que los codifican, y sus usos de estas
EA200970250A1 (ru) 2006-09-05 2010-02-26 Медарекс, Инк. Антитела к костным морфогенетическим белкам и их рецепторам и способы их применения
PL2129396T3 (pl) 2007-02-16 2014-02-28 Merrimack Pharmaceuticals Inc Przeciwciała przeciw ERBB3 i ich zastosowania
ES2660667T3 (es) 2007-05-07 2018-03-23 Protalix Ltd. Biorreactor desechable a gran escala
BRPI0814363A2 (pt) * 2007-07-25 2015-01-27 Biolex Therapeutics Inc Produtos fármacos de interferon de liberação controlada e tratamento de infecção por hcv usando os mesmos
EP2225275A4 (en) 2007-11-28 2013-04-03 Medimmune Llc PROTEIN FORMULATION
CN102271704A (zh) 2008-11-28 2011-12-07 梅里亚有限公司 重组禽流感疫苗及其用途
WO2010096545A2 (en) * 2009-02-18 2010-08-26 Biolex Thepapeutids, Inc. Aseptic bioreactor system for processing biological materials
EP2435562A1 (en) 2009-05-26 2012-04-04 Biolex Therapeutics, Inc. Compositions and methods for production of aglycosylated plasminogen
WO2011005502A2 (en) 2009-06-23 2011-01-13 Biolex Therapeutics, Inc. Methods and compositions for the cryopreservation of duckweed
RU2570554C2 (ru) 2009-08-31 2015-12-10 Роше Гликарт Аг Гуманизированные моноклональные антитела к сеа с созревшей аффинностью
KR20120101572A (ko) 2009-12-28 2012-09-13 메리얼 리미티드 재조합 ｎｄｖ 항원 및 이의 용도
EP2944322B1 (en) 2010-03-12 2018-01-17 Merial, Inc Bluetongue virus recombinant vaccines and uses thereof
WO2011140151A1 (en) 2010-05-04 2011-11-10 Dyax Corp. Antibodies against epidermal growth factor receptor (egfr)
US20120100166A1 (en) 2010-07-15 2012-04-26 Zyngenia, Inc. Ang-2 Binding Complexes and Uses Thereof
US20120213781A1 (en) 2011-02-11 2012-08-23 Zyngenia, Inc. Monovalent and Multivalent Multispecific Complexes and Uses Thereof
BR112013021460B1 (pt) 2011-03-02 2022-12-20 Roche Glycart Ag Anticorpos, composição e uso do anticorpo
EP2714738B1 (en) 2011-05-24 2018-10-10 Zyngenia, Inc. Multivalent and monovalent multispecific complexes and their uses
US9603906B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Inhalable liquid formulations of DNase I
BR112014021521B1 (pt) * 2012-04-05 2022-05-10 Basf Plant Science Company Gmbh Método para aumentar a resistência à infecção por phakopsora em uma planta de soja transgênica, método para a produção de uma planta de soja transgênica, método para a produção de um produto e método para criar uma planta transgênica resistente a fungos
EP2964669B1 (en) 2013-03-06 2018-09-12 Protalix Ltd. Use of plant cells expressing a tnfalpha polypeptide inhibitor in therapy
US20160017021A1 (en) 2013-03-06 2016-01-21 Protalix Ltd. TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
TWI463012B (zh) * 2013-04-01 2014-12-01 Lemnaceae Fermentation Inc 浮萍水解物及其用途
JP2016531088A (ja) 2013-06-17 2016-10-06 アサナ・バイオサイエンシズ，リミテッド・ライアビリティ・カンパニー ５ｔ４標的化免疫融合分子および方法
MX366208B (es) * 2013-08-21 2019-07-02 Cold Spring Harbor Laboratory Transformación de la lenteja de agua y sus usos.
CN103609304B (zh) * 2013-11-22 2015-08-19 中国科学院成都生物研究所 一种快速提高浮萍淀粉含量的方法
PH12017501834B1 (en) 2015-04-06 2024-01-17 Arcellx Inc De novo binding domain containing polypeptides and uses thereof
US10946106B2 (en) 2015-11-30 2021-03-16 The Regents Of The University Of California Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
WO2017148880A1 (en) 2016-03-01 2017-09-08 F. Hoffmann-La Roche Ag Obinutuzumab variants having altered cell death induction
IL245102A0 (en) 2016-04-13 2016-07-31 Yeda Res & Dev Cultivation of wolffia plants
EP3538551A4 (en) 2016-11-10 2020-11-11 Fortis Therapeutics, Inc. CD46 SPECIFIC EFFECTOR CELLS AND USES THEREOF
CN111511383A (zh) 2017-11-14 2020-08-07 阿奇利克斯股份有限公司 多功能免疫细胞疗法
MX2020004933A (es) 2017-11-14 2021-01-08 Arcellx Inc Polipéptidos que contienen dominios d y sus usos.
US11484604B2 (en) 2020-08-07 2022-11-01 Fortis Therapeutics, Inc. Immunoconjugates targeting CD46 and methods of use thereof
WO2022081775A1 (en) 2020-10-13 2022-04-21 Avitide LLC Aav8 affinity agents
EP4229068A1 (en) 2020-10-13 2023-08-23 Avitide LLC Affinity ligand libraries of three-helix bundle proteins and uses thereof
US20240236347A9 (en) 2021-02-19 2024-07-11 Avitide LLC Aav2 affinity agents
IL306096A (en) 2021-03-26 2023-11-01 Arcellx Inc Multifunctional immune cell therapies
CN118984834A (zh) 2021-12-24 2024-11-19 阿维泰德有限责任公司 Ch1结构域亲和配体和试剂
EP4562022A1 (en) 2022-07-29 2025-06-04 Repligen Corporation An affinity agent comprising a ligand that binds vce and comprises seq id no: 1
AU2023339047A1 (en) 2022-09-09 2025-03-20 Repligen Corporation Affinity agents

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
US4956282A (en) 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
US5256410A (en) * 1988-12-01 1993-10-26 Schering Corporation Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
US5850032A (en) 1992-04-01 1998-12-15 Union Camp Corporation Method for production of plant biological products in precocious neomorphic embryoids
US6288302B1 (en) * 1992-11-04 2001-09-11 National Science Council Of R.O.C. Application of α-amylase gene promoter and signal sequence in the production of recombinant proteins in transgenic plants and transgenic plant seeds
US5569828A (en) * 1993-03-24 1996-10-29 Pioneer Hi-Bred International, Inc. Maize chlorotic dwarf virus and resistance thereto
US5780709A (en) * 1993-08-25 1998-07-14 Dekalb Genetics Corporation Transgenic maize with increased mannitol content
US5693506A (en) 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
AU6504796A (en) 1995-07-20 1997-02-18 Washington State University Research Foundation Production of secreted foreign polypeptides in plant cell culture
US6066781A (en) 1997-02-13 2000-05-23 Applied Phytologics, Inc. Production of mature proteins in plants
JP2001512318A (ja) * 1997-02-13 2001-08-21 アプライド フィトロジックス，インコーポレイテッド 植物における成熟タンパク質の産生
IL132580A0 (en) * 1997-08-12 2001-03-19 Univ North Carolina State Genetically engineered duckweed
US7161064B2 (en) * 1997-08-12 2007-01-09 North Carolina State University Method for producing stably transformed duckweed using microprojectile bombardment
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
WO1999019497A1 (en) * 1997-10-10 1999-04-22 Yeda Research And Development Co. Ltd. Transgenic lemnaceae
US6095546A (en) * 1997-12-03 2000-08-01 Tekonsha Engineering Company Trailer hitch cover and accessory components
US6096546A (en) 1998-01-30 2000-08-01 Board Of Trustees, Rutgers, The State University Of New Jersey Methods for recovering polypeptides from plants and portions thereof
CA2323604A1 (en) * 1998-03-19 1999-09-23 Valentis, Inc. Interferon alpha plasmids and delivery systems, and methods of making and using the same
DK1305437T3 (da) * 2000-07-31 2010-12-13 Biolex Therapeutics Inc Ekspression af biologisk aktive polypeptider i andemad

Also Published As

Publication number Publication date
US6815184B2 (en) 2004-11-09
JP4795619B2 (ja) 2011-10-19
US20020088027A1 (en) 2002-07-04
JP2004504848A (ja) 2004-02-19
EP1305437A2 (en) 2003-05-02
CY1110959T1 (el) 2015-06-11
ATE479761T1 (de) 2010-09-15
AU8822601A (en) 2002-02-13
NZ523912A (en) 2005-03-24
PT1305437E (pt) 2010-11-12
CN1451048A (zh) 2003-10-22
CN101676400A (zh) 2010-03-24
US20050060776A1 (en) 2005-03-17
HK1055317A1 (en) 2004-01-02
CA2417415C (en) 2012-10-09
WO2002010414A3 (en) 2002-12-27
EP1305437B1 (en) 2010-09-01
AU2001288226B2 (en) 2007-07-26
DE60142971D1 (de) 2010-10-14
US20090282584A1 (en) 2009-11-12
US20120258491A1 (en) 2012-10-11
WO2002010414A2 (en) 2002-02-07
WO2002010414A9 (en) 2003-10-30
CA2417415A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
DK1305437T3 (da) Ekspression af biologisk aktive polypeptider i andemad
NO20015587L (no) Ekspresjon og eksport av interferon-<alfa> proteiner som Fc fusjonsproteiner
DK1114062T3 (da) Modificeret E. coli-enterotoksin II-signalpeptid og en mikroorganisme, som eksprimerer et fusionsprotein af peptidet og et heterologt protein
DE60231055D1 (de) Reinigung von peptiden unter verwendung von metall-ion-affinitätschromatographie
NO20014364D0 (no) Ny cytokin-zalphall-ligand
DK0465572T3 (da) Nye genetisk manipulerede plantefænotyper
DE60128093D1 (de) Interferon-ähnliches protein zcyto21
DE60321901D1 (de) Verbesserte bacillus-wirtszelle
DK192189A (da) Polypeptid, fremgangsmaade til inhibering af fibrinogen, fremgangsmaade til rensning af et polypeptid, gen indeholdende rekombinante dna kodende for et polypeptid, vektor, cellekultur og fremgangsmaade til fremstilling af et cysteinrigt polypeptid
BR0309401A (pt) polinucleotìdeo isolado, vetor de expressão, célula cultivada, método para produzir polipeptìdeos, e um anticorpo para um polipeptìdeo, e, anticorpo
DK1819816T3 (da) Fremgangsmåder til fremstilling og udskillelse af modificerede peptider
ATE452184T1 (de) Mikrobielle trypsinvarianten mit chymotrypsinaktivität und diese codierende nukleinsäuren
ATE404673T1 (de) Bakteriocin gegen listeria
DK1136559T3 (da) Nukleotidsekvenser, der koder for dapC-genet, og fremgangsmåde til fremstilling af L-lysin
DK0811071T3 (da) Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner
DE60029748D1 (de) Biologische bekämpfung von nematoden
FI953688A0 (fi) Kasvinsuojeluominaisuudet omaava proteiini
ATE452970T1 (de) N-desoxyribosyltransferase aus lactobacillus, entsprechende nukleinsäuren darauf und ihre verwendungen
DK595187D0 (da) Minactivin og fremgangsmaade til fremstilling deraf
ATE502049T1 (de) Peptide und polypeptide mit verbesserter stabilität, die sich für die regeneration des nervensystems eignen
DE50109097D1 (de) Promotoren zur genexpression in karyopsen von pflanzen
JP2002325574A5 (da)
KR910000180A (ko) 트롬빈 억제 활성을 갖는 폴리펩티드 및 그의 제조방법
DE60024596D1 (de) Sequenzen zur verbesserung der sekretionseffizienz von nicht-sekretierten proteinen in säugetier- und insektenzellen
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen